PCAN Podcast Episode 7: DKN-01 as monotherapy or in combination with docetaxel - presented by Dr. David R. Wise and Dr. Riccardo Lombardo

PCAN Podcast Episode 7: DKN-01 as monotherapy or in combination with docetaxel

Dr. David R. Wise

Dr. David R. Wise

Associated Prostate Cancer and Prostatic Diseases article

D. R. Wise et al. (2024) A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Prostate Cancer and Prostatic Diseases
View on publisher site
Article of record
PCAN Podcast Episode 7: DKN-01 as monotherapy or in combination with docetaxel
Dr. David R. Wise
David R. Wise
New York University Langone Medical Center
Chaired by Riccardo Lombardo
No abstract was provided for this talk.
References
  • 1.
    D. R. Wise et al. (2024) A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Prostate Cancer and Prostatic Diseases
SN Oncology Portfolio logo
SN Oncology Webinar Series
SN Oncology Portfolio
Cite as
D. R. Wise (2024, June 14), PCAN Podcast Episode 7: DKN-01 as monotherapy or in combination with docetaxel
DOI
doi.org/10.52843/cassyni.5f8kts
Export
Citations
Share
Timestamped permalink…
Details
Listed seminar This seminar is open to all
Recorded Available to all
Video length 23:46
Disclaimer The views expressed in this seminar are those of the speaker and not necessarily those of the journal